Continuing to develop clinical trial packaging standards, Clondalkin Group has invested in Prati Vegaplus booklet label manufacturing and finishing equipment.
The investment was made at the Group’s Specialist Packaging Division, at its Glasnevin site, to strengthen its compliance and quality performance across multiple study profiles. The increased capacity also enables shorter lead times and greater reliability for its international customer base in the clinical trials sector.
The installation of the machine will provide a range of benefits to the company’s growing customer base. Producing booklets of up to 64 pages, the equipment features an in line lamination unit with register control, enabling the application of Braille in register to the outer laminate. It also incorporates a hot melt coating unit and Pharma Code scanning.
The company also installed two complete finishing lines, fully equipped with inline inkjet coding and full vision inspection, bringing the site’s total number of inspection units up to four.
Barry Marron, site director, said, ‘Each booklet label we manufacture for our clinical trial customers will undergo up to 15 separate checks as part of our uncompromising quality and processes. We aim to supplement this with unparalleled levels of customer service. Our site is extensively equipped in all stages of the print and production processes from origination and print through to conversion and delivery, and this investment represents our continued commitment to improve our processes, expand our capabilities and increase our flexibility.’
